| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 |
| Sales | 2,006,000 | 1,736,000 | 1,647,000 | 1,751,000 | 1,375,000 |
| Sales Growth | +15.55% | +5.40% | -5.94% | +27.35% | -51.02% |
| Net Income | 97,000 | 143,000 | 188,000 | 190,000 | 236,000 |
| Net Income Growth | -32.17% | -23.94% | -1.05% | -19.49% | -6.72% |
Tate & Lyle Plc (TATE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Tate & Lyle is a global provider of food and beverage ingredients and solutions. Following the sale of its commodity ingredients business, as well as its exit from the sugar business a decade earlier, Tate & Lyle is now focused on specialty ingredients—sweeteners, starches, specialty gums, and soluble fiber. It has nearly 5,000 employees and operates in over 120 countries, with most of its revenue generated in North America.
Fiscal Year End Date: 03/31